androsterone
53-41-8
Androkinine
Androtine
cis-Androsterone
5alpha-Androsterone
Atromide ICI
3alpha-Hydroxy-5alpha-androstan-17-one
3-Epihydroxyetioallocholan-17-one
5alpha-Androstane-3alpha-ol-17-one
3alpha-Hydroxyetioallocholan-17-one
3alpha-Hydroxy-17-androstanone
Androstanon-3-alpha-ol-17-one
3-alpha-Hydroxy-17-androstanone
3-alpha-Hydroxy-5-alpha-androstan-17-one
3-alpha-Hydroxyetioallocholan-17-one
5-alpha-Androstan-3-alpha-ol-17-one
Caswell No. 051G
5alpha-Androstan-3alpha-ol-17-one
NSC 9898
5alpha-Androstan-17-one, 3alpha-hydroxy-
Androstan-17-one, 3-hydroxy-, (3alpha,5alpha)-
(3alpha,5alpha)-3-hydroxyandrostan-17-one
5.alpha.-Androsterone
Androstan-17-one, 3-hydroxy-, (3a,5a)-
CHEBI:16032
3.alpha.-Hydroxy-17-androstanone
Androstan-17-one, 3-hydroxy-, (3-alpha,5-alpha)-
(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
EINECS 200-173-4
UNII-C24W7J5D5R
U 6036
EPA Pesticide Chemical Code 126501
BRN 2217626
5-alpha-Androsterone
C24W7J5D5R
DTXSID3036525
5-alpha-Androstan-17-one, 3-alpha-hydroxy-
NSC-9898
ANDROSTERONE [MI]
3.alpha.-Hydroxyetioallocholan-17-one
CHEMBL87285
5.alpha.-Androstane-3.alpha.-ol-17-one
Androstan-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-
MLS000069394
DTXCID1016525
5.alpha.-Androstan-17-one, 3.alpha.-hydroxy-
4-08-00-00642 (Beilstein Handbook Reference)
5-alpha-Androstane-3alpha-ol-17-one
3alpha-hydroxy-5alpha-androstane-17-one
3-alpha-hydroxy-5alpha-Androstan-17-one
SMR000058571
3-alpha-Hydroxy-5-alpha-androstane-17-one
3-Hydroxyandrostan-17-one
3-hydroxy-(3-alpha,5-alpha)-Androstan-17-one
3.ALPHA.-HYDROXY-5.ALPHA.-ANDROSTAN-17-ONE
(3.ALPHA.,5.ALPHA.)-3-HYDROXYANDROSTAN-17-ONE
3-Epiandrosterone
Androsterone (1mg/ml in Acetonitrile)
Esterase basic kit
(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-one
3-.beta.Hydroxyandrostan-17-one
Androsterolone
Androstanon-3-.alpha.-ol-17-one
5a-Androsterone
CAS-53-41-8
5.alpha.-Androstan-3.beta.-ol-17-one
(1S,2S,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-14-one
(1S,2S,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.02,7.011,15]heptadecan-14-one
(3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta(a)phenanthren-17-one
5.alpha.-Androstan-3.alpha.-ol-17-one
AOI
Prestwick_689
MFCD00003618
5-.alpha.-Androstan-3-.alpha.-ol-17-one
5 alpha Androstan 3 alpha ol 17 one
5 alpha-Androstan-3 alpha-ol-17-one
1x8j
3-.alpha.-Hydroxy-5-.alpha.-androstan-17-one
Opera_ID_584
3 alpha Hydroxy 5 alpha Androstan 17 One
Prestwick0_000411
Prestwick1_000411
Prestwick2_000411
Prestwick3_000411
bmse000543
Epitope ID:174330
UPCMLD-DP124
5-androstan-3-ol-17-one
BSPBio_000362
MLS000563085
MLS001146886
MLS002153256
SCHEMBL269981
SPBio_002301
5a-Androstane-3a-ol-17-one
BPBio1_000400
3I+--Hydroxy-17-androstanone
UPCMLD-DP124:001
3a-Hydroxyetioallocholan-17-one
BDBM17639
3a-hydroxy-5a-androstan-17-one
NSC9898
HMS1569C04
HMS2096C04
HMS2230I18
HMS3713C04
HY-N0933
3?-HYDROXY-17-ANDROSTANONE
5alpha-Androstan-17-one-3alpha-ol
Tox21_303701
5I+--Androstan-17-one-3I+--ol
5I+--Androstan-3I+--ol-17-one
LMST02020001
s6352
(3a,5a)-3-Hydroxyandrostan-17-one
AKOS015894886
CCG-220411
FH17918
GS-3614
3I+--Hydroxy-5I+--androstane-17-one
NCGC00161664-01
NCGC00161664-02
NCGC00357021-01
AC-16145
A0646
CS-0014230
NS00010906
Androstan-17-one, 3alpha-hydroxy-, 5alpha-
C00523
D95612
Androsterone, VETRANAL(TM), analytical standard
Q422469
SR-01000759187
SR-01000759187-3
BRD-K12329651-001-18-8
086DA2D0-D9AE-4593-9E08-991AF2BF2A47
(3alpha,5beta,8alpha,10alpha,13alpha,14beta)-3-hydroxyandrostan-17-one
(3?,5?)-3-Hydroxyandrostan-17-one;3-Epihydroxyetioallocholan-17-one;Androsterone
(1S,2S,5R,7S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0?,?.0??,??]heptadecan-14-one
(3R,5S,8R,10S,13S)-3-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-17-one
200-173-4
Solubility of (3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one (C19H28O2)
The solubility of organic compounds like (3R,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one is often influenced by their structural characteristics. In this case:
In general, compounds with similar molecular frameworks as C19H28O2 might have the following solubility properties:
Ultimately, testing is essential for determining precise solubility characteristics, but the interplay of functional groups and molecular structure provides useful insights regarding expected behavior in various environments.